Arkolith/Insider Trading/MLTX/Form 4

Bodenstedt Matthias

Chief Financial OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$352K
Net Open-Market Flow
-$352K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2026Sell(S)3K$19.60$55K1.2M
Jun 17, 2026Sell(S)15K$19.68$297K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-070259) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML